Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Arrowhead Pharmaceuticals - 27 Year Stock Price History | ARWR

Historical daily share price chart and data for Arrowhead Pharmaceuticals since 1997 adjusted for splits and dividends. The latest closing stock price for Arrowhead Pharmaceuticals as of April 25, 2024 is 21.87.
  • The all-time high Arrowhead Pharmaceuticals stock closing price was 162.50 on March 24, 2000.
  • The Arrowhead Pharmaceuticals 52-week high stock price is 42.48, which is 94.2% above the current share price.
  • The Arrowhead Pharmaceuticals 52-week low stock price is 20.67, which is 5.5% below the current share price.
  • The average Arrowhead Pharmaceuticals stock price for the last 52 weeks is 30.50.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Arrowhead Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 30.2493 31.0100 39.4800 21.8700 21.8700 -28.53%
2023 30.7630 38.5100 41.3800 21.2000 30.6000 -24.56%
2022 40.1287 69.9700 69.9700 27.7900 40.5600 -38.82%
2021 71.2901 74.8300 90.4700 58.0900 66.3000 -13.59%
2020 45.7652 63.1200 85.3700 20.5600 76.7300 20.97%
2019 29.5977 13.1200 73.0100 12.0500 63.4300 410.71%
2018 11.4308 3.7200 20.3000 3.7200 12.4200 237.50%
2017 2.4264 1.6800 4.5000 1.4400 3.6800 137.42%
2016 5.1806 5.9800 8.0800 1.2400 1.5500 -74.80%
2015 6.4723 7.7100 9.0600 4.9000 6.1500 -16.67%
2014 12.7270 10.3100 26.5700 5.0000 7.3800 -31.98%
2013 4.0250 2.1000 11.0700 1.6900 10.8500 407.01%
2012 3.8995 4.1300 7.1400 2.0100 2.1400 -48.93%
2011 5.8726 10.0000 10.0000 3.5870 4.1900 -53.18%
2010 9.9126 5.4000 18.5000 5.1000 8.9500 68.87%
2009 5.7014 10.5000 12.0000 3.1270 5.3000 -42.39%
2008 21.0717 35.5000 35.5000 7.6750 9.2000 -75.66%
2007 48.5855 44.0000 76.0000 33.6000 37.8000 -13.70%
2006 50.3614 40.4000 76.5000 40.4000 43.8000 3.06%
2005 33.0205 40.0000 52.5000 21.4000 42.5000 -1.62%
2004 51.1342 19.5000 84.0000 19.5000 43.2000 232.31%
2003 8.9559 6.5000 26.0260 3.2500 13.0000 100.00%
2002 13.7847 13.0000 52.0520 1.9500 6.5000 -50.00%
2001 24.8992 39.0000 45.5000 13.0000 13.0000 -66.67%
2000 96.6880 39.0000 162.5000 35.7825 39.0000 0.00%
1999 45.1131 52.0000 97.5000 32.5000 39.0000 -25.00%
1998 37.7619 32.5000 78.0000 26.0000 52.0000 60.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.886B $0.241B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.006B 28.36
Chugai Pharmaceutical (CHGCY) Japan $52.738B 22.90
Takeda Pharmaceutical (TAK) Japan $41.871B 6.78
Merck (MKGAF) Germany $20.467B 19.31
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Sandoz Group AG (SDZNY) Switzerland $14.417B 0.00
Shionogi (SGIOY) Japan $14.386B 12.45
Neurocrine Biosciences (NBIX) United States $13.828B 57.43
United Therapeutics (UTHR) United States $11.153B 11.95
Catalent (CTLT) United States $10.126B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.608B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.824B 6.92
Ionis Pharmaceuticals (IONS) United States $6.187B 0.00
Revolution Medicines (RVMD) United States $5.861B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.072B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.015B 0.00
Indivior (INDV) United States $2.594B 12.06
Summit Therapeutics (SMMT) United States $2.519B 0.00
Corcept Therapeutics (CORT) United States $2.340B 23.66
Dyne Therapeutics (DYN) United States $2.153B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.946B 0.00
PTC Therapeutics (PTCT) United States $1.931B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.863B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.857B 11.00
Evotec AG (EVO) Germany $1.853B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.784B 18.44
Avadel Pharmaceuticals (AVDL) Ireland $1.600B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Ardelyx (ARDX) United States $1.496B 0.00
Soleno Therapeutics (SLNO) United States $1.314B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.268B 11.91
4D Molecular Therapeutics (FDMT) United States $1.241B 0.00
Pacira BioSciences (PCRX) United States $1.205B 11.99
Xencor (XNCR) United States $1.163B 0.00
Collegium Pharmaceutical (COLL) United States $1.160B 7.14
Centessa Pharmaceuticals (CNTA) United Kingdom $0.949B 0.00
Cronos Group (CRON) Canada $0.947B 0.00
Cassava Sciences (SAVA) United States $0.897B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.868B 0.00
Sage Therapeutics (SAGE) United States $0.841B 0.00
USANA Health Sciences (USNA) United States $0.841B 13.24
Relay Therapeutics (RLAY) United States $0.840B 0.00
Enliven Therapeutics (ELVN) United States $0.819B 0.00
ARS Pharmaceuticals (SPRY) United States $0.797B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.727B 0.00
Ocular Therapeutix (OCUL) United States $0.719B 0.00
Silence Therapeutics (SLN) United Kingdom $0.667B 0.00
ProKidney (PROK) United States $0.622B 0.00
Siga Technologies (SIGA) United States $0.616B 9.12
Lyell Immunopharma (LYEL) United States $0.586B 0.00
Savara (SVRA) United States $0.586B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.551B 0.00
Verve Therapeutics (VERV) United States $0.550B 0.00
OmniAb (OABI) United States $0.534B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Altimmune (ALT) United States $0.502B 0.00
Exscientia (EXAI) United Kingdom $0.499B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.445B 0.00
KalVista Pharmaceuticals (KALV) United States $0.437B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Esperion Therapeutics (ESPR) United States $0.403B 0.00
Heron Therapeutics (HRTX) United States $0.398B 0.00
Tourmaline Bio (TRML) United States $0.395B 0.00
Organogenesis (ORGO) United States $0.393B 74.50
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.55
Harrow (HROW) United States $0.363B 0.00
Bioventus (BVS) United States $0.329B 0.00
Lyra Therapeutics (LYRA) United States $0.312B 0.00
Fractyl Health (GUTS) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
Aquestive Therapeutics (AQST) United States $0.286B 0.00
Nanobiotix S.A (NBTX) France $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.273B 0.00
Black Diamond Therapeutics (BDTX) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.261B 0.00
Pyxis Oncology (PYXS) United States $0.259B 0.00
Nektar Therapeutics (NKTR) United States $0.253B 0.00
Metagenomi (MGX) United States $0.253B 0.00
Adherex Technologies (FENC) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.232B 0.00
Foghorn Therapeutics (FHTX) United States $0.222B 0.00
Avita Medical (RCEL) United States $0.221B 0.00
Acrivon Therapeutics (ACRV) United States $0.215B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.197B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Century Therapeutics (IPSC) United States $0.192B 0.00
MediWound (MDWD) Israel $0.167B 0.00
Achieve Life Sciences (ACHV) Canada $0.156B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Incannex Healthcare (IXHL) Australia $0.143B 0.00
Elite Pharmaceuticals (ELTP) United States $0.135B 12.63
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.69
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Inotiv (NOTV) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
GlycoMimetics (GLYC) United States $0.120B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Citius Pharmaceuticals (CTXR) United States $0.114B 0.00
OptiNose (OPTN) United States $0.104B 0.00
Eliem Therapeutics (ELYM) United States $0.101B 0.00
FibroGen (FGEN) United States $0.097B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
ProPhase Labs (PRPH) United States $0.091B 0.00
AlloVir (ALVR) United States $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.66
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
Carisma Therapeutics (CARM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.84
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
JanOne (JAN) United States $0.041B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
Protara Therapeutics (TARA) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
Nutriband (NTRB) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.73
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.10
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.05